Community Research and Development Information Service - CORDIS

ScanBalt BioRegion to Collaborate on Cancer

Contributed by: ScanBalt

Up to forty three (43) percent of all cancer cases can be prevented by prevention programmes according to The World Health Organization (WHO). Thereby coordinated cross-border efforts have a significant potential for improving the health of the populations in the Baltic Sea Region.
Hans-Robert Metelmann, Professor at Greifswald University, Chairman of ScanBalt, says “Prevention is a pillar of health care. Effective cancer prevention is a task between life sciences, humanities, social sciences, politics and public-private collaboration on drug development. In ScanBalt BioRegion, the established platform for cross-border collaboration, we have a unique tool to effectively improve health. We will now explore the possibilities to establish concrete projects and involve key stakeholders from research, politics, and education, industry and opinion makers. It is the aim to make cancer prevention an integral component of the social and personal behaviour around the Baltic Sea Region”.

Collaboration on cancer in ScanBalt BioRegion is also expected to be an important theme for ScanBalt Academy. ScanBalt Academy is a group of distinguished and prominent life scientists from academia as well as industry and government. The vision is to promote research quality in ScanBalt BioRegion, to Identify and promote fields of research where collaborative trans-national public-private efforts in ScanBalt BioRegion can become global leaders and to be ambassadors with the purpose of attracting human, financial and industrial resources.

The inauguration assembly of the Academy will take place in Schwerin/Germany, ScanBalt House, 12th of March 2008. The assembly will be hosted by the Minister President of Mecklenburg-Vorpommern, Dr. Harald Ringstorff.

For further information please contact Professor Hans-Robert Metelmann at hrm@scanbalt.org

About ScanBalt BioRegion and ScanBalt
ScanBalt BioRegion is composed of Life Science and biotechnology actors in the Nordic countries, Balticum, Poland, Northern part of Germany and North western Russia. The ScanBalt BioRegion have 11 countries and 85 million people, more than 60 universities and 2149 life science/biotech companies including 671 research based biotech SME´s.

ScanBalt facilitates and co-ordinates regional and national efforts in ScanBalt BioRegion. It enhances visibility and attracts human, industrial and financial resources to the region and to the members. ScanBalt encompasses regional and national life science triple helix networks between companies, universities, hospitals, tech transfer organisations and public authorities.

Read more at http://www.scanbalt.org

Contributor

Organisation

    ScanBalt
    Arne Jacobsens AllŽ 15
    2300 Copenhagen
    Denmark

Contact

Related information

Countries (24)

  • Austria, Belgium, Czech Republic, Germany, Denmark, Estonia, Greece, Spain, Finland, France, Hungary, Ireland, Italy, Lithuania, Luxembourg, Latvia, Malta, Netherlands, Poland, Portugal, Sweden, Slovenia, Slovakia, United Kingdom
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top